Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors. 1995

A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
International Agency for Research on Cancer, Lyon, France.

Point mutations in the p53 tumor suppressor gene are the most common genetic alterations in human cancers. The nature and location of these mutations can be informative in assessing the importance of putative carcinogenic agents. Potential associations between a given carcinogen and a specific mutation pattern can be substantiated when the exposure history of the patients is known. While the past exposure to environmental risk factors is often difficult to determine, documented occupational exposure to carcinogens presents a unique situation for evaluating this approach. Analysis usually involves working with paraffin-embedded tissues, fixed under conditions suboptimal for genetic analysis and stored for many years, since frozen tissues are not available in sufficient numbers. The particular methodological problems encountered with fixed samples are discussed here, using as illustration an ongoing study of oncogene and tumor suppressor gene mutations in archived bladder tumors of workers exposed to aromatic amines and nonexposed patients.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
January 1996, Cancer research,
A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
January 2021, BioMed research international,
A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
October 1986, Journal of occupational medicine. : official publication of the Industrial Medical Association,
A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
April 1959, The Journal of medical laboratory technology,
A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
May 1998, British journal of cancer,
A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
February 2005, Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases,
A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
March 2003, Human mutation,
A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
February 2014, The Science of the total environment,
A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
July 2007, Journal of occupational health,
A Esteve, and T Sørlie, and G Martel-Planche, and M Hollstein, and I Kusters, and J Lewalter, and P Vineis, and M Stephan-Odenthal, and R Montesano
September 1995, Journal of the National Cancer Institute,
Copied contents to your clipboard!